Clinical Trials Directory

Trials / Completed

CompletedNCT01092767

Study to Determine if the Valiant Stent Graft is Safe and Effective in Treating Patients Who Have a Blunt Thoracic Aortic Injury

Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System for the Endovascular Treatment of Blunt Thoracic Aortic Injuries (RESCUE)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Medtronic Cardiovascular · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if the Valiant stent graft is safe and effective in treating patients who have a blunt thoracic aortic injury (BTAI). BTAI is when the aorta has been injured due to traumatic force to the chest area. It is commonly caused by motor vehicle accidents. In most cases it is life threatening and the standard treatment is surgery. Many times when a person has a BTAI they also have other injuries that can affect the results of the surgery. Since stent grafting has been an effective way to treat other aortic conditions such as aneurysms (bulge in aorta wall), it is believed that the Valiant stent graft would be effective in treating BTAI. A stent graft is a woven polyester tube (graft) supported by a metal frame of strong but flexible nitinol (type of metal) springs (stent) that is placed in the aorta to help seal the injury and keep it from bleeding.

Conditions

Interventions

TypeNameDescription
DEVICEValiant Thoracic Stent Graft with the Captivia Delivery SystemAll subjects will be implanted with this device

Timeline

Start date
2010-04-01
Primary completion
2012-04-01
Completion
2017-05-01
First posted
2010-03-25
Last updated
2021-10-29
Results posted
2014-03-28

Locations

25 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01092767. Inclusion in this directory is not an endorsement.